10 Best Medical Stocks to Buy According to Billionaires

3. Intuitive Surgical, Inc. (NASDAQ:ISRG)

Number of Billionaire Investors: 18

Number of Hedge Fund Holders: 95

Intuitive Surgical, Inc. (NASDAQ:ISRG) has an elaborate ecosystem of services and products that provides robotic-assisted surgical solutions and invasive care. Its products include the Ion Endoluminal and the Da Vinci Surgical systems. In 2024, Intuitive Surgical, Inc. (NASDAQ:ISRG) expanded its installed system base to 9,902, reflecting a 15% growth. It also grew its number of performed procedures by 17%, showing its technology’s global adoption.

Its fiscal Q4 2024 results also showed considerable growth, with Da Vinci procedures increasing by 18%. Overall revenue also increased by 25% to $2.41 billion, beating the consensus of $2.24 billion. Intuitive Surgical, Inc. (NASDAQ:ISRG) holds a significant position in the surgical robotics market. According to Grand View Research, the surgical robotics market is expected to grow at a compound annual growth rate of 9.5% until 2030. The global market is anticipated to be worth around $7.4 billion by then, up from $4.3 billion last year. The market holds potential for growth in the coming years and decades, supported by the rapid advancement of healthcare technologies.

Intuitive Surgical, Inc.’s (NASDAQ:ISRG) management has expressed optimism for 2025, expecting a 13%-16% growth in worldwide da Vinci procedures. In a report released on April 2, Patrick Wood from Morgan Stanley maintained a Buy rating on Intuitive Surgical, Inc. (NASDAQ:ISRG) and set a price target of $650.00. The firm said that growth in the company’s general surgery segment is more diversified than expected, which presents an attractive entry point for investors in conjunction with the recent stock pullback. The company takes the third spot on our list of the best medical stocks to buy now.